• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LI-RADS v2014 肝细胞癌分类:钆喷酸葡胺增强 MRI 与钆塞酸二钠增强 MRI 的个体内比较。

LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.

机构信息

Department of Radiology, Chonbuk National University Medical School and Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Chonbuk, 54907, South Korea.

Research Institute of Clinical Medicine of Chonbuk National University, Jeonju, South Korea.

出版信息

Eur Radiol. 2019 Jan;29(1):401-410. doi: 10.1007/s00330-018-5559-z. Epub 2018 Jun 19.

DOI:10.1007/s00330-018-5559-z
PMID:29922928
Abstract

OBJECTIVES

To use Liver Imaging Reporting and Data System (LI-RADS) categorization and features of hepatocellular carcinomas (HCCs) to intraindividually compare gadopentetate dimeglumine-enhanced magnetic resonance imaging (Gd-DTPA-MRI) and gadoxetic acid-enhanced MRI (Gd-EOB-MRI), before and after applying modified major features.

METHODS

Of 77 HCCs in 64 patients analysed, 17 HCCs were confirmed histopathologically and 46 patients had cirrhosis. Gd-EOB-MRI and Gd-DTPA-MRI were evaluated for the presence of major and ancillary features by two radiologists. LI-RADS categorization was done for Gd-DTPA-MRI (LI-RADS-DTPA) and for Gd-EOB-MRI before and after applying modified major features (hepatobiliary phase [HBP] hypointensity as an additional major feature, LI-RADS-EOBm1; HBP hypointense rim as capsule appearance, LI-RADS-EOBm2; and transitional phase [TP] hypointensity as washout appearance, LI-RADS-EOBm3). Sensitivities of LR-5 categorization for the diagnosis of HCC were compared.

RESULTS

Washout (p=0.012) and capsule appearance (p<0.001) were less frequently observed on Gd-EOB-MRI. Sensitivity for LR-5 categorization was significantly higher with LI-RADS-DTPA compared with LI-RADS-EOB (p=0.001) and LI-RADS-EOBm2 (p=0.004), while sensitivity for LR-5 categorization with LI-RADS-EOBm1 (p=0.210) and LI-RADS-EOBm3 (p=0.727) was comparable.

CONCLUSION

Modifying LI-RADS for use with Gd-EOB-MRI, such as applying HBP hypointensity as an additional major feature or using TP hypointensity as washout appearance, can improve the sensitivity for the detection of HCC.

KEY POINTS

• Adding HBP hypointensity as additional major feature improved sensitivity of LR-5 categorization. • Adding TP hypointensity as modified washout appearance improved sensitivity of LR-5 categorization. • Sensitivities for LR-5 classification were comparable between LI-RADS-DTPA, LI-RADS-EOBm1, and LI-RADS-EOBm3.

摘要

目的

使用肝脏成像报告和数据系统(LI-RADS)分类和肝细胞癌(HCC)的特征,在个体内比较钆喷酸葡胺增强磁共振成像(Gd-DTPA-MRI)和钆塞酸二钠增强磁共振成像(Gd-EOB-MRI),在应用改良主要特征之前和之后。

方法

在 64 例患者的 77 个 HCC 中,17 个 HCC 经组织病理学证实,46 例患者有肝硬化。两位放射科医生评估了 Gd-EOB-MRI 和 Gd-DTPA-MRI 主要和辅助特征的存在。对 Gd-DTPA-MRI(LI-RADS-DTPA)和应用改良主要特征(肝胆期[HBP]低信号作为附加主要特征,LI-RADS-EOBm1;HBP 低信号边缘作为包膜外观,LI-RADS-EOBm2;过渡期[TP]低信号作为洗脱外观,LI-RADS-EOBm3)前后的 Gd-EOB-MRI 进行 LI-RADS 分类。比较了 LR-5 分类对 HCC 诊断的敏感性。

结果

Gd-EOB-MRI 上观察到洗脱(p=0.012)和包膜外观(p<0.001)的频率较低。与 LI-RADS-EOB(p=0.001)和 LI-RADS-EOBm2(p=0.004)相比,LI-RADS-DTPA 的 LR-5 分类的敏感性显著更高,而 LI-RADS-EOBm1(p=0.210)和 LI-RADS-EOBm3(p=0.727)的 LR-5 分类的敏感性相当。

结论

对 LI-RADS 进行修改以应用于 Gd-EOB-MRI,例如将 HBP 低信号作为附加主要特征,或使用 TP 低信号作为洗脱外观,可提高 HCC 的检测敏感性。

关键要点

  1. 添加 HBP 低信号作为附加主要特征可提高 LR-5 分类的敏感性。

  2. 添加 TP 低信号作为改良洗脱外观可提高 LR-5 分类的敏感性。

  3. 在 LI-RADS-DTPA、LI-RADS-EOBm1 和 LI-RADS-EOBm3 之间,LR-5 分类的敏感性相当。

相似文献

1
LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.LI-RADS v2014 肝细胞癌分类:钆喷酸葡胺增强 MRI 与钆塞酸二钠增强 MRI 的个体内比较。
Eur Radiol. 2019 Jan;29(1):401-410. doi: 10.1007/s00330-018-5559-z. Epub 2018 Jun 19.
2
Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017).在 1.5T 场强下使用肝脏影像报告和数据系统(LI-RADS v.2017)评估钆塞酸二钠与钆喷替酸葡甲胺对比用于肝细胞癌检测的效能。
Cancer Imaging. 2018 Dec 7;18(1):48. doi: 10.1186/s40644-018-0183-3.
3
Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.肝脏影像报告和数据系统(LI-RADS)v2014对钆塞酸二钠增强MRI上肝细胞癌的分类:与多期多层螺旋CT的比较
J Magn Reson Imaging. 2017 Mar;45(3):731-740. doi: 10.1002/jmri.25406. Epub 2016 Jul 30.
4
Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.肝细胞癌-胆管细胞癌混合型:钆塞酸增强磁共振成像的 LI-RADS v2017 分类用于鉴别诊断和预后评估。
Eur Radiol. 2019 Jan;29(1):373-382. doi: 10.1007/s00330-018-5605-x. Epub 2018 Jun 28.
5
Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.采用扩散加权成像的细胞外对比增强 MRI 对 HCC 诊断的前瞻性比较:与使用 LI-RADS 的钆塞酸对比剂的比较。
Eur Radiol. 2020 Jul;30(7):3723-3734. doi: 10.1007/s00330-020-06753-5. Epub 2020 Mar 3.
6
Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.肝细胞癌在对比增强计算机断层扫描、钆喷酸葡胺增强磁共振成像和钆塞酸二钠增强磁共振成像上的个体内影像特征比较
Acta Radiol. 2018 Jun;59(6):639-648. doi: 10.1177/0284185117728534. Epub 2017 Aug 20.
7
Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?钆塞酸增强 MRI 中新的肝细胞癌诊断标准的回顾性验证:肝胆期低信号是否可以借助辅助特征替代廓清作为替代方法?
Eur Radiol. 2019 Apr;29(4):1724-1732. doi: 10.1007/s00330-018-5727-1. Epub 2018 Sep 25.
8
LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features.钆塞酸增强 MRI 的 LI-RADS 治疗反应分类:与 mRECIST 的诊断性能比较及辅助特征的附加价值。
Eur Radiol. 2020 May;30(5):2861-2870. doi: 10.1007/s00330-019-06623-9. Epub 2020 Jan 31.
9
The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.钆贝葡胺增强肝胆期 MRI 病变低信号强度在 LI-RADS v2018 标准中作为 HCC 分类的另一个主要影像学特征的作用。
Eur Radiol. 2021 Oct;31(10):7715-7724. doi: 10.1007/s00330-021-07807-y. Epub 2021 Mar 29.
10
Liver imaging reporting and data system diagnostic performance in hepatocellular carcinoma when modifying the definition of "washout" on gadoxetic acid-enhanced magnetic resonance imaging.钆塞酸增强磁共振成像中修改“洗脱”定义时肝成像报告和数据系统在肝细胞癌中的诊断性能。
Arab J Gastroenterol. 2024 Feb;25(1):58-63. doi: 10.1016/j.ajg.2023.12.012. Epub 2024 Jan 20.

引用本文的文献

1
A T2 weighted imaging-based radiomics nomogram for the classification of hepatic blood-rich lesions: hepatocellular carcinoma and benign liver lesions.基于T2加权成像的放射组学列线图用于肝血供丰富病变的分类:肝细胞癌和良性肝病变
Discov Oncol. 2025 Jul 1;16(1):1223. doi: 10.1007/s12672-025-02868-7.
2
Modified LR-5 criteria based on gadoxetic acid can improve the sensitivity in the diagnosis of hepatocellular carcinoma.基于钆塞酸的改良LR-5标准可提高肝细胞癌诊断的敏感性。
World J Radiol. 2025 Mar 28;17(3):103822. doi: 10.4329/wjr.v17.i3.103822.
3
Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis.

本文引用的文献

1
Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.肝细胞癌在对比增强计算机断层扫描、钆喷酸葡胺增强磁共振成像和钆塞酸二钠增强磁共振成像上的个体内影像特征比较
Acta Radiol. 2018 Jun;59(6):639-648. doi: 10.1177/0284185117728534. Epub 2017 Aug 20.
2
Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).钆塞酸二钠增强磁共振成像对小的富血供肝细胞癌的诊断准确性及肝脏影像报告和数据系统(LI-RADS)的符合率
PLoS One. 2017 May 30;12(5):e0178495. doi: 10.1371/journal.pone.0178495. eCollection 2017.
3
在LR-3或LR-4观察中,并发LR-5是否与肝细胞癌的更高发生率相关?一项个体参与者数据荟萃分析。
Abdom Radiol (NY). 2025 Apr;50(4):1533-1546. doi: 10.1007/s00261-024-04580-6. Epub 2024 Sep 27.
4
Evidence Supporting Diagnostic Value of Liver Imaging Reporting and Data System for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.支持肝脏影像报告和数据系统对基于CT和MR成像的肝细胞癌诊断的诊断价值的证据:一项系统评价和荟萃分析。
J Biomed Phys Eng. 2024 Feb 1;14(1):5-20. doi: 10.31661/jbpe.v0i0.2211-1562. eCollection 2024 Feb.
5
Diagnostic Value of CT Delayed Phase Images Added to Gd-EOB-DTPA MRI for HCC Diagnosis in LR-3/4 Lesions.CT延迟期图像联合钆塞酸二钠MRI对肝脏影像报告和数据系统(LR)3/4期肝细胞癌(HCC)诊断的价值
Int J Gen Med. 2023 Jun 12;16:2383-2391. doi: 10.2147/IJGM.S410123. eCollection 2023.
6
LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging.基于钆塞酸二钠增强磁共振成像的2018版肝脏影像报告和数据系统(LI-RADS)用于直径小于1.0厘米的肝细胞癌。
Eur Radiol. 2023 Aug;33(8):5792-5800. doi: 10.1007/s00330-023-09554-8. Epub 2023 Apr 5.
7
LI-RADS v2018: utilizing ancillary features on gadoxetic acid-enhanced MRI to improve the diagnostic performance of small hapatocellular carcinoma (≤ 20 mm).肝脏影像报告和数据系统(LI-RADS)v2018:利用钆塞酸二钠增强磁共振成像(MRI)的辅助特征提高小肝细胞癌(≤20毫米)的诊断效能
Abdom Radiol (NY). 2023 Jun;48(6):1987-1994. doi: 10.1007/s00261-023-03871-8. Epub 2023 Mar 20.
8
The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.在钆塞酸二钠增强磁共振成像中,强化包膜和改良包膜表现对肝脏影像报告和数据系统(LI-RADS)诊断直径≤3.0 cm肝细胞癌的作用。
Eur Radiol. 2023 Aug;33(8):5801-5811. doi: 10.1007/s00330-023-09487-2. Epub 2023 Mar 10.
9
Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation.前瞻性评估钆塞酸增强磁共振成像和计算机断层扫描在肝细胞癌检测和移植适应证评估中的作用,并与离体组织病理学进行相关性分析。
Cancer Imaging. 2023 Feb 25;23(1):22. doi: 10.1186/s40644-023-00532-3.
10
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid.肝细胞癌的磁共振成像:钆塞酸二钠和钆特酸对比剂前瞻性个体内对头比较。
Sci Rep. 2022 Nov 3;12(1):18583. doi: 10.1038/s41598-022-23397-1.
Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.肝脏影像报告和数据系统 CT 和钆塞酸增强 MRI 与弥散加权成像。
Eur Radiol. 2017 Oct;27(10):4394-4405. doi: 10.1007/s00330-017-4804-1. Epub 2017 Apr 3.
4
Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.钆塞酸二钠增强MRI肝胆期平滑低信号环在识别肿瘤包膜及诊断肝细胞癌中的附加价值
Eur Radiol. 2017 Jun;27(6):2610-2618. doi: 10.1007/s00330-016-4634-6. Epub 2016 Oct 21.
5
Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.肝脏影像报告和数据系统(LI-RADS)v2014对钆塞酸二钠增强MRI上肝细胞癌的分类:与多期多层螺旋CT的比较
J Magn Reson Imaging. 2017 Mar;45(3):731-740. doi: 10.1002/jmri.25406. Epub 2016 Jul 30.
6
Liver Imaging Reporting and Data System v2014 With Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging: Validation of LI-RADS Category 4 and 5 Criteria.《肝脏影像报告和数据系统(2014版)与钆塞酸二钠增强磁共振成像:LI-RADS 4类和5类标准的验证》
Invest Radiol. 2016 Aug;51(8):483-90. doi: 10.1097/RLI.0000000000000258.
7
Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.肝细胞癌 ⩽3 cm 的肝细胞特异性对比增强磁共振成像的诊断标准。
J Hepatol. 2016 May;64(5):1099-1107. doi: 10.1016/j.jhep.2016.01.018. Epub 2016 Jan 25.
8
Liver Imaging Reporting and Data System:: Substantial Discordance Between CT and MR for Imaging Classification of Hepatic Nodules.肝脏影像报告和数据系统:CT与MR在肝结节影像分类上存在显著差异。
Acad Radiol. 2016 Mar;23(3):344-52. doi: 10.1016/j.acra.2015.11.002. Epub 2016 Jan 7.
9
Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?钆塞酸二钠增强MRI对肝细胞癌的无创诊断:肝胆期低信号能否作为廓清的替代指标?
Eur Radiol. 2015 Oct;25(10):2859-68. doi: 10.1007/s00330-015-3686-3. Epub 2015 Mar 14.
10
Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.原发性肝癌中的癌症干细胞:病理概念与影像学表现
Korean J Radiol. 2015 Jan-Feb;16(1):50-68. doi: 10.3348/kjr.2015.16.1.50. Epub 2015 Jan 9.